Public health management of pertussis in adults: Practical challenges and future strategies.
Hum Vaccin Immunother
; 20(1): 2377904, 2024 Dec 31.
Article
em En
| MEDLINE
| ID: mdl-39016172
ABSTRACT
A panel of 24 international experts met in July 2022 to discuss challenges associated with pertussis detection, monitoring, and vaccination in adults; conclusions from this meeting are presented. There has been a shift in the epidemiology of pertussis toward older children and adults. This shift has been attributed to the waning of infection- or vaccine-induced immunity, newer detection techniques causing detection bias, and possibly the replacement of whole-cell pertussis with acellular vaccines in high-income countries, which may lead to immunity waning more quickly. The burden of adult pertussis is still likely under-ascertained due to widespread under-recognition by healthcare professionals (HCPs), under-diagnosis, and under-reporting in this age group. Non-standardized testing guidance and varied case definitions have contributed to under-reporting. Key barriers to HCP engagement with the tetanus, diphtheria, and pertussis (Tdap) vaccine include low awareness, lack of time/funding, and lack of motivation due to low prioritization of Tdap.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Coqueluche
/
Vacinação
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article